Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Clover Corporation Ltd

Consumer Defensive AU CLV

0.5AUD
-(-%)

Last update at 2025-06-17T01:24:00Z

Day Range

0.490.50
LowHigh

52 Week Range

0.330.59
LowHigh

Fundamentals

  • Previous Close 0.50
  • Market Cap82.66M
  • Volume211387
  • P/E Ratio16.50
  • Dividend Yield3.66%
  • EBITDA7.04M
  • Revenue TTM72.49M
  • Revenue Per Share TTM0.44
  • Gross Profit TTM 20.62M
  • Diluted EPS TTM0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Income before tax 8.36M 9.84M 8.18M 17.66M 13.96M
Minority interest - - - - -
Net income 6.21M 7.13M 6.00M 12.49M 10.10M
Selling general administrative 5.51M 4.56M 3.79M 5.36M 5.32M
Selling and marketing expenses 5.69M 4.00M 3.13M 3.79M 3.60M
Gross profit 23.74M 21.53M 18.24M 29.71M 23.92M
Reconciled depreciation 0.92M 0.71M 0.71M 0.68M 0.41M
Ebit 9.09M 10.29M 8.58M 18.24M 14.29M
Ebitda 10.01M 11.01M 9.28M 18.92M 14.70M
Depreciation and amortization 0.92M 0.71M 0.71M 0.68M 0.41M
Non operating income net other - - - - -
Operating income 9.09M 10.29M 8.58M 18.24M 14.29M
Other operating expenses 71.51M 60.26M 51.69M 70.60M 63.51M
Interest expense 0.73M 0.46M 0.40M 0.59M 0.33M
Tax provision 2.16M 2.71M 2.17M 5.17M 3.86M
Interest income 1.22M 1.11M 1.34M 0.63M 0.71M
Net interest income -0.73000M -0.45500M -0.40100M -0.58800M -0.31800M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.16M 2.71M 2.17M 5.17M 3.86M
Total revenue 79.88M 70.66M 60.51M 88.28M 76.68M
Total operating expenses 15.37M 11.13M 9.43M 12.03M 10.74M
Cost of revenue 56.14M 49.13M 42.27M 58.57M 52.76M
Total other income expense net -0.19300M -0.45500M -0.40100M -0.58800M -0.33000M
Discontinued operations - - - - -
Net income from continuing ops 6.21M 7.13M 6.00M 12.49M 10.10M
Net income applicable to common shares 6.21M 7.13M 6.00M 12.49M 10.10M
Preferred stock and other adjustments - - - - -
Breakdown 2024-07-31 2023-07-31 2022-07-31 2021-07-31 2020-07-31
Type yearly yearly yearly yearly yearly
Date 2024-07-31 2023-07-31 2022-07-31 2021-07-31 2020-07-31
Total assets 84.39M 86.20M 90.60M 78.73M 81.49M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - 1.74M 1.22M 1.60M 1.12M
Total liab 17.32M 19.05M 27.56M 20.32M 23.92M
Total stockholder equity 67.07M 67.15M 63.04M 58.42M 57.57M
Deferred long term liab - - - - -
Other current liab - 2.20M 6.43M 1.18M 2.92M
Common stock - 36.27M 35.60M 35.60M 35.37M
Capital stock 36.27M 36.27M 35.60M 35.60M 35.37M
Retained earnings 32.00M 31.74M 28.45M 22.98M 21.96M
Other liab - 1.18M 0.02M 0.03M 0.08M
Good will 1.91M 1.91M 1.91M 1.91M 1.91M
Other assets - 1.29M 0.84M 0.91M 1.08M
Cash 12.26M 9.44M 10.11M 9.09M 9.24M
Cash and equivalents - - - - -
Total current liabilities 9.83M 8.29M 17.25M 7.84M 10.94M
Current deferred revenue - - - - -
Net debt - 2.27M 1.97M 5.09M 5.38M
Short term debt - 2.13M 1.78M 1.74M 1.71M
Short long term debt 3.44M 1.74M 1.67M 1.62M 1.62M
Short long term debt total - 11.71M 12.08M 14.19M 14.62M
Other stockholder equity - -0.18900M -1.01100M -0.16600M 0.24M
Property plant equipment - 11.34M 9.18M 8.10M 5.85M
Total current assets 56.88M 60.01M 66.86M 54.74M 59.07M
Long term investments 11.25M 11.66M 11.82M 13.07M 13.58M
Net tangible assets - 65.24M 61.13M 56.51M 55.66M
Short term investments - - - - -
Net receivables 12.00M 11.95M 19.56M 13.27M 16.78M
Long term debt 5.03M 7.69M 9.24M 11.45M 12.90M
Inventory 29.55M 36.88M 35.97M 30.78M 31.93M
Accounts payable 5.08M 3.96M 9.04M 4.92M 6.30M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -0.85500M -1.01100M -0.16600M 0.24M
Additional paid in capital - - - - -
Common stock total equity - - - - 35.37M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 27.51M 26.20M 23.74M 24.00M 22.41M
Capital lease obligations 1.92M 2.28M 1.17M 1.11M 0.10M
Long term debt total - 9.58M 10.30M 12.45M 12.90M
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Investments -2.52900M -1.59800M -1.83100M -3.46100M -10.48100M
Change to liabilities -8.69000M 0.07M -2.55100M -2.07300M 3.94M
Total cashflows from investing activities -2.52900M -1.59800M -1.83100M -4.01700M -10.58900M
Net borrowings -1.96400M -2.30000M -1.55800M 1.24M 9.27M
Total cash from financing activities -4.88100M -3.96400M -6.54700M -1.67400M 6.17M
Change to operating activities 1.48M 1.97M 0.07M -0.11700M -0.25700M
Net income 6.21M 7.13M 6.00M 12.49M 10.10M
Change in cash -0.67400M 1.02M -0.15000M 0.97M 0.38M
Begin period cash flow 10.11M 9.09M 9.24M 8.27M 7.89M
End period cash flow 9.44M 10.11M 9.09M 9.24M 8.27M
Total cash from operating activities 6.74M 7.84M 8.23M 6.66M 4.79M
Issuance of capital stock - - - - -
Depreciation 0.81M 0.71M 0.71M 0.68M 0.41M
Other cashflows from investing activities -0.89000M -0.89000M -0.89000M -3.46100M -10.48100M
Dividends paid -2.91700M -1.66400M -4.98900M -2.91000M 3.10M
Change to inventory -0.91200M -5.18800M 1.16M -4.25200M -7.91300M
Change to account receivables 7.61M -6.29700M 3.52M 1.67M -3.18900M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.22900M -0.13400M -0.11500M 2.80M 14.33M
Change to netincome 0.19M 0.41M 0.34M 0.66M 0.66M
Capital expenditures 1.64M 1.60M 1.83M 0.56M 0.11M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.73000M -0.45600M -0.40100M -0.58800M -0.31800M
Stock based compensation - - - - -
Other non cash items - -7.84500M -6.71100M -13.16600M -10.51000M
Free cash flow -1.63900M 6.25M -1.83100M -0.55600M -0.10800M

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CLV
Clover Corporation Ltd		 - -% 0.50 16.50 26.18 1.14 0.96 0.77 6.99
A2M
A2 Milk Company Ltd		 0.05 0.63% 8.00 37.14 26.18 3.37 4.60 3.06 18.88
BGA
Bega Cheese Ltd		 -0.09 1.63% 5.43 50.77 25.25 0.48 1.66 0.59 27.41
RIC
Ridley Corporation Ltd		 0.03 0.87% 2.88 22.12 15.50 0.84 3.05 0.85 16.39
CBO
Cobram Estate Olives Ltd		 -0.03 1.43% 2.07 41.40 - 3.62 2.78 4.76 15.60

Reports Covered

Stock Research & News

View All

Profile

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm, a microencapsulated powders with the addition of Hi-DHA tuna and/or algal oils. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.

Clover Corporation Ltd

39 Pinnacle Road, Altona North, VIC, Australia, 3025

Key Executives

Name Title Year Born
Mr. Peter J. Davey GAICD, gradDip Bus., MBA CEO, MD & Exec. Director NA
Mr. Andrew G. M. Allibon C.A. CFO & Company Sec. NA
Mr. David Pierotti Operations Mang. NA
Mr. Timothy Murphy Human Resource & Payroll Mang. NA
S. Poothong Chief Commercial Officer NA
Mr. Peter J. Davey GAICD, gradDip Bus., MBA CEO, MD & Executive Director NA
Mr. Andrew G. M. Allibon C.A. CFO & Company Secretary NA
Mr. David Pierotti Director of Operations NA
Mr. Bassam Hallak Director of Sales & Marketing NA
Ms. Anne Roach General Manager of People & Culture NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.